The AIM index inched its way higher once again on Wednesday, moving within just a few points of the pre-COVID highs. The index closed up one at 973.62
- N4 Pharma up 30%
- Mysale Group up 29%
- Orosur up 16%
- 4D Pharma down 37%
- Adams down 17%
N4 Pharma [LON:N4P] was the day’s biggest riser, with the company finding itself back in favour. There’s been no fresh news released, but anticipation of an update appears to be driving support.
Online retailer Mysale Group [LON:MYSL] also jumped on Wednesday, adding 29% but with no news supporting the move. The stock now trades at levels not seen for almost 18 months, but remains well below previous highs.
An update on clinical trials saw shares in 4D Pharma [LON:DDDD] slump in Wednesday, shedding 30% by the close. Despite the headline results seeming to be positive, investors had clearly expected more and heavy selling saw the shares lose the gains accrued over the last six weeks.
Investment management company Adams [LON:ADA] also found itself sliding on Wednesday although with the stock trading on a 38% spread and no buying demand seen, the shift, which was millions wiped off the company’s market cap, does have the potential to look overdone.
A notable mention for Orosur Mining [LON:OMI], which added 16%, adding to last week’s gains in a day of relatively thin trade. There’s been no update on the joint venture plans, but evidently investors remain confident over prospects here.